Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia
- PMID: 32894311
- DOI: 10.1007/s00125-020-05245-x
Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia
Abstract
Obesity and insulin resistance are associated with the development of type 2 diabetes. It is well accepted that beta cell dysfunction is required for hyperglycaemia to occur. The prevailing view is that, in the presence of insulin resistance, beta cell dysfunction that occurs early in the course of the disease process is the critical abnormality. An alternative model has been proposed in which primary beta cell overstimulation results in insulin hypersecretion that then leads to the development of obesity and insulin resistance, and ultimately to beta cell exhaustion. In this review, data from preclinical and clinical studies, including intervention studies, are discussed in the context of these models. The preponderance of the data supports the view that an early beta cell functional defect is the more likely mechanism underlying the pathogenesis of hyperglycaemia in the majority of individuals who develop type 2 diabetes. Graphical abstract.
Keywords: Beta cell function; Hyperinsulinaemia; Insulin resistance; Obesity; Prediabetes; Review; Type 2 diabetes.
Comment in
-
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes.Diabetologia. 2021 Oct;64(10):2138-2146. doi: 10.1007/s00125-021-05505-4. Epub 2021 Jul 22. Diabetologia. 2021. PMID: 34296322
-
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter].Diabetologia. 2021 Oct;64(10):2345-2347. doi: 10.1007/s00125-021-05511-6. Epub 2021 Jul 29. Diabetologia. 2021. PMID: 34324020 No abstract available.
Similar articles
-
Novel canine models of obese prediabetes and mild type 2 diabetes.Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E38-48. doi: 10.1152/ajpendo.00466.2009. Epub 2009 Oct 20. Am J Physiol Endocrinol Metab. 2010. PMID: 19843874 Free PMC article.
-
BRSK2 in pancreatic β cells promotes hyperinsulinemia-coupled insulin resistance and its genetic variants are associated with human type 2 diabetes.J Mol Cell Biol. 2023 Nov 27;15(5):mjad033. doi: 10.1093/jmcb/mjad033. J Mol Cell Biol. 2023. PMID: 37188647 Free PMC article.
-
The required beta cell research for improving treatment of type 2 diabetes.J Intern Med. 2013 Sep;274(3):203-14. doi: 10.1111/joim.12096. Epub 2013 Jun 21. J Intern Med. 2013. PMID: 23751050 Review.
-
Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes.Diabet Med. 2012 Aug;29(8):972-9. doi: 10.1111/j.1464-5491.2012.03655.x. Diabet Med. 2012. PMID: 22443306 Review.
-
Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction.Curr Diabetes Rev. 2012 Mar;8(2):76-83. doi: 10.2174/157339912799424564. Curr Diabetes Rev. 2012. PMID: 22229253 Review.
Cited by
-
Emerging Roles of Metallothioneins in Beta Cell Pathophysiology: Beyond and Above Metal Homeostasis and Antioxidant Response.Biology (Basel). 2021 Feb 26;10(3):176. doi: 10.3390/biology10030176. Biology (Basel). 2021. PMID: 33652748 Free PMC article. Review.
-
Coffee and Lower Risk of Type 2 Diabetes: Arguments for a Causal Relationship.Nutrients. 2021 Mar 31;13(4):1144. doi: 10.3390/nu13041144. Nutrients. 2021. PMID: 33807132 Free PMC article. Review.
-
Frequency and correlates of poor glycemic control in patients with type 2 diabetes at Jimma Medical Centre, Ethiopia: a cross-sectional study.Pan Afr Med J. 2024 Jan 8;47:7. doi: 10.11604/pamj.2024.47.7.37452. eCollection 2024. Pan Afr Med J. 2024. PMID: 38371649 Free PMC article.
-
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes.Diabetologia. 2021 Oct;64(10):2138-2146. doi: 10.1007/s00125-021-05505-4. Epub 2021 Jul 22. Diabetologia. 2021. PMID: 34296322
-
Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications.Biology (Basel). 2023 May 16;12(5):726. doi: 10.3390/biology12050726. Biology (Basel). 2023. PMID: 37237539 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical